JP4707321B2 - アンギオテンシンｉｉアゴニストとして有用な三環式化合物 - Google Patents

アンギオテンシンｉｉアゴニストとして有用な三環式化合物 Download PDF

Info

Publication number
JP4707321B2
JP4707321B2 JP2003500062A JP2003500062A JP4707321B2 JP 4707321 B2 JP4707321 B2 JP 4707321B2 JP 2003500062 A JP2003500062 A JP 2003500062A JP 2003500062 A JP2003500062 A JP 2003500062A JP 4707321 B2 JP4707321 B2 JP 4707321B2
Authority
JP
Japan
Prior art keywords
compound
formula
sulfonamide
ylmethylphenyl
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2003500062A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004533457A5 (ko
JP2004533457A (ja
Inventor
アンデルス・ハルベルグ
マティアス・アルテルマン
Original Assignee
ヴィコール・ファルマ・アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0113129A external-priority patent/GB0113129D0/en
Priority claimed from GB0121611A external-priority patent/GB0121611D0/en
Priority claimed from GB0201794A external-priority patent/GB0201794D0/en
Application filed by ヴィコール・ファルマ・アーベー filed Critical ヴィコール・ファルマ・アーベー
Priority claimed from PCT/GB2002/002563 external-priority patent/WO2002096883A1/en
Publication of JP2004533457A publication Critical patent/JP2004533457A/ja
Publication of JP2004533457A5 publication Critical patent/JP2004533457A5/ja
Application granted granted Critical
Publication of JP4707321B2 publication Critical patent/JP4707321B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2003500062A 2001-05-31 2002-05-30 アンギオテンシンｉｉアゴニストとして有用な三環式化合物 Expired - Lifetime JP4707321B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0113129.1 2001-05-31
GB0113129A GB0113129D0 (en) 2001-05-31 2001-05-31 Pharmaceutically-useful compounds
GB0121611.8 2001-09-07
GB0121611A GB0121611D0 (en) 2001-09-07 2001-09-07 Pharmaceutically-useful-compounds
US35095902P 2002-01-25 2002-01-25
US60/350,959 2002-01-25
GB0201794.5 2002-01-26
GB0201794A GB0201794D0 (en) 2002-01-26 2002-01-26 Pharmaceutically-useful compounds
PCT/GB2002/002563 WO2002096883A1 (en) 2001-05-31 2002-05-30 Tricyclic compounds useful as angiotensin ii agonists

Publications (3)

Publication Number Publication Date
JP2004533457A JP2004533457A (ja) 2004-11-04
JP2004533457A5 JP2004533457A5 (ko) 2006-01-05
JP4707321B2 true JP4707321B2 (ja) 2011-06-22

Family

ID=32872450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003500062A Expired - Lifetime JP4707321B2 (ja) 2001-05-31 2002-05-30 アンギオテンシンｉｉアゴニストとして有用な三環式化合物

Country Status (2)

Country Link
JP (1) JP4707321B2 (ko)
KR (1) KR100938817B1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006109048A1 (en) * 2005-04-12 2006-10-19 Vicore Pharma Ab New tricyclic angiotensin ii agonists
AU2008264458B2 (en) * 2007-06-20 2013-01-24 Mitsubishi Tanabe Pharma Corporation Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
RU2688163C2 (ru) * 2013-03-15 2019-05-20 Юниверсити Оф Саузерн Калифорния Способы, соединения и композиции для лечения связанных с ангиотензином заболеваний
EP3127554A4 (en) * 2014-04-03 2017-12-06 National Cerebral and Cardiovascular Center Medicine for suppressing malignant tumor metastasis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444067A (en) * 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
WO2000068226A1 (de) * 1999-05-05 2000-11-16 Aventis Pharma Deutschland Gmbh 1-(p-thienylbenzyl)-imidazole als agonisten von angiotensin-(1-7)-rezeptoren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198438A (en) * 1991-05-07 1993-03-30 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444067A (en) * 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
WO2000068226A1 (de) * 1999-05-05 2000-11-16 Aventis Pharma Deutschland Gmbh 1-(p-thienylbenzyl)-imidazole als agonisten von angiotensin-(1-7)-rezeptoren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate

Also Published As

Publication number Publication date
KR100938817B1 (ko) 2010-01-26
KR20040011519A (ko) 2004-02-05
JP2004533457A (ja) 2004-11-04

Similar Documents

Publication Publication Date Title
US8124638B2 (en) Tricyclic compounds useful as angiotensin II agonists
JP5625029B2 (ja) 新規な三環系アンジオテンシンｉｉアゴニスト
AU2002257970A1 (en) Tricyclic compounds useful as angiotensin II agonists
JP5718301B2 (ja) 新規な三環系アンジオテンシンｉｉアゴニスト
WO2004046137A1 (en) New tricyclic angiotensin ii agonists
WO2004085420A1 (en) Bicyclic compounds useful as angiotensin ii agonists
JP2013067631A (ja) 新規な二環式アンジオテンシンｉｉアゴニスト
WO2003064414A1 (en) Tricyclic compounds useful as angiotensin ii agonists
WO2004046128A1 (en) New bicyclic angiotensin ii agonists
JP4707321B2 (ja) アンギオテンシンｉｉアゴニストとして有用な三環式化合物

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050517

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090113

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090402

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090409

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090702

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090908

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091120

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091130

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100308

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100601

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100917

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20101007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101102

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110121

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110215

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110315

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250